Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis
- Resource Type
- article
- Source
- Frontiers in Oncology, Vol 14 (2024)
- Subject
Sacituzumab govitecan triple negative metastatic breast cancer retrospective study Italy Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 - Language
- English
- ISSN
- 2234-943X